{
  "company": {
    "name": "Mediar Therapeutics",
    "website": "https://mediartx.com/",
    "record": "https://startuphistory.org/c/mediartx.com"
  },
  "status": null,
  "history_since": "2026-11-12T11:29:41.164Z",
  "baseline": {
    "snapshot_id": "641c8b62ed3708c6f2d93cc2f81a06c2fd218f85901e5f228f0797b12a8c03bc",
    "observed_at": "2026-11-12T11:29:41.164Z",
    "headline": "Pursuing Unexplored Targets to halt and reverse fibrotic activity in the clinic",
    "description": "New perspective. Novel targets. Clinical trials. The myofibroblast is responsible for depositing collagen, extracellular matrix, and maintaining the pro-fibrotic micro-environment in organ systems. By",
    "evidence": "https://www.mediartx.com/",
    "evidence_kind": "live_capture",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-12T11:29:41.164Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2026-11-12T11:29:41.164Z",
      "variants": [
        {
          "headline": "Pursuing Unexplored Targets to halt and reverse fibrotic activity in the clinic",
          "subhead": "New perspective. Novel targets. Clinical trials. The myofibroblast is responsible for depositing collagen, extracellular matrix, and maintaining the pro-fibrotic micro-environment in organ systems. By",
          "observed_at": "2026-11-12T11:29:41.164Z",
          "evidence": "https://www.mediartx.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Pursuing Unexplored Targets to halt and reverse fibrotic activity in the clinic",
      "subhead": "New perspective. Novel targets. Clinical trials. The myofibroblast is responsible for depositing collagen, extracellular matrix, and maintaining the pro-fibrotic micro-environment in organ systems. By",
      "from": "2026-11-12T11:29:41.164Z",
      "to": "2026-11-12T11:29:41.164Z",
      "captures": 1,
      "evidence": "https://www.mediartx.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "on": "2026-11-12T11:29:41.164Z"
      },
      "current": true
    }
  ],
  "changes": [],
  "update": null,
  "same_space": [
    {
      "name": "Mirador Therapeutics",
      "record": "https://startuphistory.org/c/miradortx.com",
      "basis": "description_similarity",
      "category": null
    },
    {
      "name": "MediLink Therapeutics",
      "record": "https://startuphistory.org/c/medilinkthera.com",
      "basis": "description_similarity",
      "category": null
    },
    {
      "name": "Cyclarity Therapeutics",
      "record": "https://startuphistory.org/c/cyclaritytx.com",
      "basis": "category",
      "category": "Mitochondrial and metabolic therapeutics"
    },
    {
      "name": "Maze Therapeutics",
      "record": "https://startuphistory.org/c/mazetx.com",
      "basis": "category",
      "category": "Mitochondrial and metabolic therapeutics"
    },
    {
      "name": "Sarcomatrix",
      "record": "https://startuphistory.org/c/sarcomatrix.com",
      "basis": "category",
      "category": "Mitochondrial and metabolic therapeutics"
    },
    {
      "name": "Miphic",
      "record": "https://startuphistory.org/c/miphic.co",
      "basis": "category",
      "category": "Mitochondrial and metabolic therapeutics"
    }
  ],
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Mediar Therapeutics” company record, https://startuphistory.org/c/mediartx.com"
}